Alzamend Neuro, Inc. (ALZN) vs COSCIENS Biopharma Inc. (CSCIF)
Alzamend Neuro, Inc. and COSCIENS Biopharma Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and COSCIENS Biopharma Inc. are of similar size ($8.8M and $8.6M). Alzamend Neuro, Inc. has negative trailing earnings, so its P/E is not meaningful; COSCIENS Biopharma Inc. trades at 1.0×. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs 0.00%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 13 metrics below, COSCIENS Biopharma Inc. leads on 8 and Alzamend Neuro, Inc. on 5.
Valuation
Profitability
| Metric | ALZN | CSCIF | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 46.48% | 65.16% |
| Operating margin | 0.00% | (71.13%) | 0.00% |
| Net margin | 0.00% | 75.11% | 0.00% |
| Free cash flow margin | 0.00% | (40.36%) | 0.00% |
| Return on equity | (163.23%) | 59.74% | (57.72%) |
| Return on assets | (122.36%) | 28.24% | (49.22%) |
| Return on invested capital | 0.00% | (40.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack